174 related articles for article (PubMed ID: 37194932)
21. NADPH quinone oxidoreductase 1 mediates breast cancer cell resistance to thymoquinone-induced apoptosis.
Sutton KM; Doucette CD; Hoskin DW
Biochem Biophys Res Commun; 2012 Sep; 426(3):421-6. PubMed ID: 22960073
[TBL] [Abstract][Full Text] [Related]
22. Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo.
Lei X; Lv X; Liu M; Yang Z; Ji M; Guo X; Dong W
Biochem Biophys Res Commun; 2012 Jan; 417(2):864-8. PubMed ID: 22206670
[TBL] [Abstract][Full Text] [Related]
23. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells.
Roepke M; Diestel A; Bajbouj K; Walluscheck D; Schonfeld P; Roessner A; Schneider-Stock R; Gali-Muhtasib H
Cancer Biol Ther; 2007 Feb; 6(2):160-9. PubMed ID: 17218778
[TBL] [Abstract][Full Text] [Related]
24. Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer.
Barkat MA; Harshita ; Ahmad J; Khan MA; Beg S; Ahmad FJ
Curr Drug Targets; 2018; 19(1):70-80. PubMed ID: 28606050
[TBL] [Abstract][Full Text] [Related]
25. Anticancer activity of thymoquinone against breast cancer cells: Mechanisms of action and delivery approaches.
Shabani H; Karami MH; Kolour J; Sayyahi Z; Parvin MA; Soghala S; Baghini SS; Mardasi M; Chopani A; Moulavi P; Farkhondeh T; Darroudi M; Kabiri M; Samarghandian S
Biomed Pharmacother; 2023 Sep; 165():114972. PubMed ID: 37481931
[TBL] [Abstract][Full Text] [Related]
26. Thymoquinone attenuates phosphorylation of AKT to inhibit kidney cancer cell proliferation.
Dera A; Rajagopalan P
J Food Biochem; 2019 Apr; 43(4):e12793. PubMed ID: 31353586
[TBL] [Abstract][Full Text] [Related]
27. Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species.
Koka PS; Mondal D; Schultz M; Abdel-Mageed AB; Agrawal KC
Exp Biol Med (Maywood); 2010 Jun; 235(6):751-60. PubMed ID: 20511679
[TBL] [Abstract][Full Text] [Related]
28. Protective Effects of Black Cumin (
Hannan MA; Zahan MS; Sarker PP; Moni A; Ha H; Uddin MJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445781
[TBL] [Abstract][Full Text] [Related]
29. Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma.
Das S; Dey KK; Dey G; Pal I; Majumder A; MaitiChoudhury S; kundu SC; Mandal M
PLoS One; 2012; 7(10):e46641. PubMed ID: 23077516
[TBL] [Abstract][Full Text] [Related]
30. Thymoquinone and its therapeutic potentials.
Darakhshan S; Bidmeshki Pour A; Hosseinzadeh Colagar A; Sisakhtnezhad S
Pharmacol Res; 2015; 95-96():138-58. PubMed ID: 25829334
[TBL] [Abstract][Full Text] [Related]
31. Modulation of gene expression by thymoquinone conjugated zinc oxide nanoparticles arrested cell cycle, DNA damage and increased apoptosis in triple negative breast cancer cell line MDA-MB-231.
Sjs B; K K; A P; P H; B SR; S S
Drug Dev Ind Pharm; 2021 Dec; 47(12):1943-1951. PubMed ID: 35510706
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: A comprehensive review.
Majdalawieh AF; Fayyad MW
Int Immunopharmacol; 2015 Sep; 28(1):295-304. PubMed ID: 26117430
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic perspectives on cancer chemoprevention/chemotherapeutic effects of thymoquinone.
Kundu J; Chun KS; Aruoma OI; Kundu JK
Mutat Res; 2014 Oct; 768():22-34. PubMed ID: 25847385
[TBL] [Abstract][Full Text] [Related]
34. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
Jafri SH; Glass J; Shi R; Zhang S; Prince M; Kleiner-Hancock H
J Exp Clin Cancer Res; 2010 Jul; 29(1):87. PubMed ID: 20594324
[TBL] [Abstract][Full Text] [Related]
35. Thymoquinone inhibits proliferation and invasion of human nonsmall-cell lung cancer cells via ERK pathway.
Yang J; Kuang XR; Lv PT; Yan XX
Tumour Biol; 2015 Jan; 36(1):259-69. PubMed ID: 25238880
[TBL] [Abstract][Full Text] [Related]
36. Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo.
Xu D; Ma Y; Zhao B; Li S; Zhang Y; Pan S; Wu Y; Wang J; Wang D; Pan H; Liu L; Jiang H
Oncol Rep; 2014 May; 31(5):2063-70. PubMed ID: 24603952
[TBL] [Abstract][Full Text] [Related]
37. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
[TBL] [Abstract][Full Text] [Related]
38. Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-γ pathway.
Woo CC; Loo SY; Gee V; Yap CW; Sethi G; Kumar AP; Tan KH
Biochem Pharmacol; 2011 Sep; 82(5):464-75. PubMed ID: 21679698
[TBL] [Abstract][Full Text] [Related]
39. Thymoquinone induces apoptosis in bladder cancer cell via endoplasmic reticulum stress-dependent mitochondrial pathway.
Zhang M; Du H; Huang Z; Zhang P; Yue Y; Wang W; Liu W; Zeng J; Ma J; Chen G; Wang X; Fan J
Chem Biol Interact; 2018 Aug; 292():65-75. PubMed ID: 29981725
[TBL] [Abstract][Full Text] [Related]
40. Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity.
Al-Hayali M; Garces A; Stocks M; Collins H; Bradshaw TD
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
